Cobicistat + Darunavir + Emtricitabine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tabletsAU ES GB800 mg / 150 mg / 200 mg / 10 mgJanssen-Cilag International N.V
darunavir + cobicistat + emtricitabina + tenofovir alafenamidaES800 mg / 150 mg / 200 mg / 10 mgJanssen-Cilag International N.V
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamideUS800 mg / 150 mg / 200 mg / 10 mgJanssen Products LP
cobicistat + emtricitabine + darunavir + tenofovir alafenamideAU——
信澤力膜衣錠TW
  • tablet Cobicistat + Darunavir + Emtricitabine + Tenofovir Alafenamide
嬌生股份有限公司
SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tabletsAU
  • tablet Cobicistat 150 mg + Darunavir 800 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 10 mg
Janssen-Cilag Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.